MedTrace Logo

EyeConic: Qualification for Cone-Optogenetics

NCT05294978 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-07-31

No results posted yet for this study

Summary

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Conditions

  • Retinal Dystrophies

Interventions

DIAGNOSTIC_TEST

Optical coherence tomography (OCT)

Data of macular optical coherence tomography (OCT)

Sponsors & Collaborators

  • Institute of Molecular and Clinical Ophthalmology Basel

    lead OTHER

Principal Investigators

  • Nicolas Feltgen, MD · University Hospital Basel/Institute of Molecular and Clinical Ophthalmology Basel, Switzerland

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • China
  • Germany
  • Hungary
  • Italy
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05294978 on ClinicalTrials.gov